Tag Archives: active

Tremfya (guselkumab) Approved by U.S. Food and Drug Administration as the First Selective Interleukin (IL)-23 Inhibitor for Active Psoriatic Arthritis

Print this page HORSHAM, PA, July 14, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) has approved Tremfya (guselkumab) for adult patients with active psoriatic arthritis (PsA), a chronic progressive disease characterized by painful joints and skin inflammation.[1],[2] Tremfya is the first treatment… Read More »

Ways to stay active as you get older

by Angel Jony Data from the Office for National Statistics predicts that, in 50 years, there will be an additional 8.2 million people in the UK aged 65 and over as the country’s population continues to age. And according to the NHS, many adults aged 65+ spend an average of at least 10 hours per day sitting… Read More »